Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Amortizatization of Intangibles of $562000.0 for Q1 2026, down 57.62% year-over-year from $1.3 million in Q1 2025, and up 27.73% quarter-over-quarter from $440000.0 in Q4 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Amortizatization of Intangibles for 5 consecutive years, with $562000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 57.62% year-over-year to $562000.0; the TTM figure through Mar 2026 stood at $2.9 million (down 68.07% YoY), while the FY2025 annual figure was $3.7 million, down 60.11% from the prior year.
- Amortizatization of Intangibles climbed to $562000.0 in Q1 2026 per LXRX's latest filing, from $440000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.3 million in Q2 2024 and bottomed at $440000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $1.6 million across 4 years, with a median of $1.4 million in 2024.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 5.22% in 2025 and fell as far as 76.68% in 2025.
- Lexicon Pharmaceuticals' Amortizatization of Intangibles stood at $2.0 million in 2023, then declined by 5.84% to $1.9 million in 2024, then sank by 76.68% to $440000.0 in 2025, then advanced by 27.73% to $562000.0 in 2026.
- Business Quant data shows LXRX's Amortizatization of Intangibles at $562000.0 in Q1 2026, $440000.0 in Q4 2025, and $732000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 730,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 730,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2010 | 2.60 Mn |